About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
HALO - Halozyme Therapeutic...| Previous Close | $41.07 | Open | $40.98 |
| Volume | 682.2K | Market Cap | 5.848B |
| Yield | Last Dividend |
| Hedge Funds Are Cashing Out Of Halozyme ... | 07/19/21 |
| No summary available. | |
| Analyzing Halozyme Therapeutics''s Unusu... | 07/16/21 |
| On Friday, shares of Halozyme Therapeutics (NASDAQ: HALO ) saw unusual options activity. After the option alert, the stock price moved down to $42.55.... | |
| Janssen''s Darzalex Faspro Wins FDA Appr... | 07/12/21 |
| The FDA has approved Janssen Biotech Inc''s , a unit of Johnson & Johnson (NYSE: JNJ ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for multip... | |
| Bioplastics company Chip[s] Board to exp... | 07/01/21 |
| Bioplastics company Chip[s] Board to expand after successful fundraise, advised by M&A specialists Ciesco Submitted 01/07/2021 - 10:47am Specialist M&... | |
| ViiV Healthcare, Halozyme partner to dev... | 06/23/21 |
| ViiV Healthcare has signed a global collaboration and license agreement with Halozyme Therapeutics to develop ultra-long-acting medicines for HIV. The... | |
| Halozyme Collaborates with ViiV Healthca... | 06/22/21 |
| Biopharmaceutical company Halozyme Therapeutics (HALO) has entered into a global collaboration and licensing agreement with ViiV Healthcare to further... | |
| Halozyme Therapeutics Inc (HALO) Preside... | 06/08/21 |
| Related Stocks: HALO , | |
| Halozyme to Present at Upcoming Investor... | 05/28/21 |
| SAN DIEGO, May 28, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it will participate at the following investor ... | |
| Halozyme Therapeutics Stock Gives Every ... | 05/20/21 |
| Related Stocks: HALO , | |
| Halozyme Therapeutics (NASDAQ:HALO) Upda... | 05/11/21 |
| Halozyme Therapeutics (NASDAQ:HALO) issued an update on its FY21 earnings guidance on Monday morning. The company provided earnings per share guidance... | |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO... | 05/11/21 |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Helen Torley sold 50,000 shares of the businesss stock in a transaction on Tuesday, May 11th. The shares... | |
| Halozyme Therapeutics Inc (HALO) Preside... | 05/11/21 |
| Related Stocks: HALO , | |
| Halozyme Therapeutics (NASDAQ:HALO) Anno... | 05/11/21 |
| Halozyme Therapeutics (NASDAQ:HALO) posted its quarterly earnings data on Monday. The biopharmaceutical company reported $0.37 earnings per share for ... | |
| Whats your take on Halozyme Therapeutics... | 05/10/21 |
| Earnings results for Halozyme Therapeutics , Analyst Opinion on Halozyme Therapeutics , Earnings and Valuation of (NASDAQ:HALO), Stock market Insights... | |
| Halozyme Therapeutics Inc (HALO) Q1 2021... | 05/10/21 |
| HALO earnings call for the period ending March 31, 2021. | |
| Halozyme Therapeutics, Inc. (HALO) CEO H... | 05/10/21 |
| No summary available. | |
| Halozyme Therapeutics Inc. Shares Approa... | 02/05/21 |
| Halozyme Therapeutics Inc. shares closed today at 1.2% below its 52 week high of $49.50, giving the company a market cap of $6B. The stock is current... | |
| Halozyme Therapeutics Inc. Shares Approa... | 12/24/20 |
| Halozyme Therapeutics Inc. shares closed today at 1.6% below its 52 week high of $43.62, giving the company a market cap of $5B. The stock is current... | |
| Halozyme Therapeutics Inc. Shares Near 5... | 12/22/20 |
| Halozyme Therapeutics Inc. shares closed today at 0.9% below its 52 week high of $43.62, giving the company a market cap of $5B. The stock is current... | |
| Halozyme Therapeutics Inc. Shares Climb ... | 12/21/20 |
| Halozyme Therapeutics Inc. shares closed 1.7% higher than its previous 52 week high, giving the company a market cap of $5B. The stock is currently u... | |
| Halozyme Therapeutics Inc. Shares Climb ... | 12/18/20 |
| Halozyme Therapeutics Inc. shares closed 0.8% higher than its previous 52 week high, giving the company a market cap of $5B. The stock is currently u... | |
| Halozyme Therapeutics Inc. Shares Close ... | 12/17/20 |
| Halozyme Therapeutics Inc. shares closed today at 0.1% below its 52 week high of $42.58, giving the company a market cap of $5B. The stock is current... | |
| Halozyme Therapeutics Inc. Shares Close ... | 12/15/20 |
| Halozyme Therapeutics Inc. shares closed today at 0.9% below its 52 week high of $42.57, giving the company a market cap of $5B. The stock is current... | |
| Halozyme Therapeutics Inc. Shares Approa... | 12/14/20 |
| Halozyme Therapeutics Inc. shares closed today at 1.7% below its 52 week high of $42.57, giving the company a market cap of $5B. The stock is current... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Burdeshaw Investing | Matthew Burdeshaw | 56.00 % | Subscribe |
| Momentum Stocks Only | Hao | 46.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
| ITM Options Only | Hao | 29.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
